Identifying Phosphodiesterase-5 Inhibitors with Drug Repurposing Approach: Implications in Vasodysfunctional Disorders
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Khan, Mohd Shahnawaz | - |
dc.contributor.author | Mohammad, Hamza Ahmad | - |
dc.contributor.author | Shahwan, Moyad | - |
dc.contributor.author | Yadav, Dharmendra Kumar | - |
dc.contributor.author | Anwar, Saleha | - |
dc.contributor.author | Shamsi, Anas | - |
dc.date.accessioned | 2024-05-25T12:00:20Z | - |
dc.date.available | 2024-05-25T12:00:20Z | - |
dc.date.issued | 2024-05 | - |
dc.identifier.issn | 2191-1363 | - |
dc.identifier.issn | 2191-1363 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/91241 | - |
dc.description.abstract | Phosphodiesterase type 5 (PDE5) is a multidomain protein that plays a crucial role in regulating cellular cyclic guanosine monophosphate (cGMP), a key signaling molecule involved in various physiological processes. Dysregulation of PDE5 and cGMP signaling is associated with a range of vasodysfunctional disorders, necessitating the development of effective therapeutic interventions. This study adopts comprehensive approach, combining virtual screening and molecular dynamics (MD) simulations, to repurpose FDA-approved drugs as potential PDE5 inhibitors. The initial focus involves selecting compounds based on their binding affinity. Shortlisted compounds undergo a meticulous analysis for their drug profiling and biological significance, followed by the activity evaluation and interaction analysis. Notably, based on binding potential and drug profiling, two molecules, Dutasteride and Spironolactone, demonstrate strong potential as PDE5 inhibitors. Furthermore, all atom MD simulations were employed (500 ns) to explore dynamic behavior of Dutasteride and Spironolactone in complexes with PDE5. Principal components analysis (PCA) and free energy landscape (FEL) analyses are further leveraged to decipher that the binding of Dutasteride and Spironolactone stabilizes the structure of PDE5 with minimal conformational changes. In summary, Dutasteride and Spironolactone exhibit remarkable affinity for PDE5 and possess characteristics that suggest their potential as therapeutic agents for conditions associated with PDE5 dysfunction. Phosphodiesterase type 5 plays a crucial role in regulating key signaling molecules involved in various physiological processes. This study combines virtual screening and molecular dynamics simulations to investigate the repurposing of FDA-approved drugs as potential PDE5 inhibitors.image | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY-V C H VERLAG GMBH | - |
dc.title | Identifying Phosphodiesterase-5 Inhibitors with Drug Repurposing Approach: Implications in Vasodysfunctional Disorders | - |
dc.type | Article | - |
dc.identifier.wosid | 001117843000001 | - |
dc.identifier.doi | 10.1002/open.202300196 | - |
dc.identifier.bibliographicCitation | CHEMISTRYOPEN, v.13, no.5 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85178886125 | - |
dc.citation.title | CHEMISTRYOPEN | - |
dc.citation.volume | 13 | - |
dc.citation.number | 5 | - |
dc.type.docType | Article; Early Access | - |
dc.publisher.location | 독일 | - |
dc.subject.keywordAuthor | drug repurposing | - |
dc.subject.keywordAuthor | drug design | - |
dc.subject.keywordAuthor | molecular dynamics | - |
dc.subject.keywordAuthor | signaling molecules | - |
dc.subject.keywordAuthor | virtual screening | - |
dc.subject.keywordPlus | POTENTIAL THERAPEUTIC APPLICATIONS | - |
dc.subject.keywordPlus | PDE5 INHIBITORS | - |
dc.subject.keywordPlus | PERSPECTIVE | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.